Annual CFO:
-$69.10M-$44.16M(-177.05%)Summary
- As of today, SLNO annual cash from operations is -$69.10 million, with the most recent change of -$44.16 million (-177.05%) on December 31, 2024.
- During the last 3 years, SLNO annual cash from operations has fallen by -$41.33 million (-148.82%).
- SLNO annual cash from operations is now -7705.69% below its all-time high of -$885.20 thousand, reached on December 31, 2013.
Performance
SLNO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$12.61M+$20.14M(+61.50%)Summary
- As of today, SLNO quarterly cash from operations is -$12.61 million, with the most recent change of +$20.14 million (+61.50%) on June 30, 2025.
- Over the past year, SLNO quarterly cash from operations has increased by +$5.04 million (+28.57%).
- SLNO quarterly cash from operations is now -704.73% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$84.28M+$5.04M(+5.65%)Summary
- As of today, SLNO TTM cash from operations is -$84.28 million, with the most recent change of +$5.04 million (+5.65%) on June 30, 2025.
- Over the past year, SLNO TTM cash from operations has dropped by -$41.45 million (-96.79%).
- SLNO TTM cash from operations is now -4142.26% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SLNO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -177.1% | +28.6% | -96.8% |
| 3Y3 Years | -148.8% | -172.9% | -262.5% |
| 5Y5 Years | -297.7% | -93.0% | -259.6% |
SLNO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -232.5% | at low | -170.8% | +61.5% | -305.6% | +5.7% |
| 5Y | 5-Year | -297.7% | at low | -172.9% | +61.5% | -305.6% | +5.7% |
| All-Time | All-Time | -7705.7% | at low | -704.7% | +61.5% | -4142.3% | +5.7% |
SLNO Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$12.61M(+61.5%) | -$84.28M(+5.6%) |
| Mar 2025 | - | -$32.75M(-36.5%) | -$89.32M(-29.3%) |
| Dec 2024 | -$69.10M(-177.0%) | -$23.99M(-60.7%) | -$69.10M(-34.4%) |
| Sep 2024 | - | -$14.93M(+15.4%) | -$51.42M(-20.1%) |
| Jun 2024 | - | -$17.65M(-40.9%) | -$42.83M(-39.3%) |
| Mar 2024 | - | -$12.53M(-98.4%) | -$30.74M(-23.3%) |
| Dec 2023 | -$24.94M(-20.0%) | -$6.31M(+0.3%) | -$24.94M(-4.9%) |
| Sep 2023 | - | -$6.33M(-13.8%) | -$23.77M(-7.6%) |
| Jun 2023 | - | -$5.57M(+17.3%) | -$22.09M(-4.5%) |
| Mar 2023 | - | -$6.73M(-30.8%) | -$21.15M(-1.8%) |
| Dec 2022 | -$20.78M(+25.2%) | -$5.14M(-10.5%) | -$20.78M(+7.6%) |
| Sep 2022 | - | -$4.66M(-0.8%) | -$22.50M(+3.2%) |
| Jun 2022 | - | -$4.62M(+27.4%) | -$23.25M(+12.7%) |
| Mar 2022 | - | -$6.36M(+7.3%) | -$26.64M(+4.1%) |
| Dec 2021 | -$27.77M(-10.1%) | -$6.86M(-27.0%) | -$27.77M(+0.0%) |
| Sep 2021 | - | -$5.41M(+32.5%) | -$27.77M(+2.7%) |
| Jun 2021 | - | -$8.01M(-7.0%) | -$28.53M(-5.5%) |
| Mar 2021 | - | -$7.49M(-9.0%) | -$27.05M(-7.3%) |
| Dec 2020 | -$25.22M(-45.2%) | -$6.87M(-11.4%) | -$25.22M(-7.6%) |
| Sep 2020 | - | -$6.16M(+5.7%) | -$23.43M(-6.6%) |
| Jun 2020 | - | -$6.53M(-15.5%) | -$21.99M(-13.7%) |
| Mar 2020 | - | -$5.66M(-11.5%) | -$19.35M(-11.3%) |
| Dec 2019 | -$17.38M | -$5.08M(-7.6%) | -$17.38M(-8.4%) |
| Sep 2019 | - | -$4.72M(-21.2%) | -$16.04M(-14.6%) |
| Jun 2019 | - | -$3.89M(-5.6%) | -$13.99M(-8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.69M(+1.3%) | -$12.85M(-10.0%) |
| Dec 2018 | -$11.68M(-17.4%) | -$3.74M(-39.6%) | -$11.68M(-9.4%) |
| Sep 2018 | - | -$2.68M(+2.7%) | -$10.68M(-6.3%) |
| Jun 2018 | - | -$2.75M(-9.1%) | -$10.04M(+2.4%) |
| Mar 2018 | - | -$2.52M(+7.8%) | -$10.29M(-3.4%) |
| Dec 2017 | -$9.95M(+26.3%) | -$2.73M(-33.7%) | -$9.95M(-0.4%) |
| Sep 2017 | - | -$2.04M(+31.7%) | -$9.91M(+7.0%) |
| Jun 2017 | - | -$2.99M(-37.1%) | -$10.65M(+9.0%) |
| Mar 2017 | - | -$2.18M(+18.8%) | -$11.70M(+13.3%) |
| Dec 2016 | -$13.50M(-31.1%) | -$2.69M(+3.5%) | -$13.50M(+4.9%) |
| Sep 2016 | - | -$2.79M(+31.0%) | -$14.19M(+0.5%) |
| Jun 2016 | - | -$4.04M(-1.4%) | -$14.26M(-14.3%) |
| Mar 2016 | - | -$3.98M(-17.9%) | -$12.47M(-21.1%) |
| Dec 2015 | -$10.30M(-129.7%) | -$3.38M(-18.1%) | -$10.30M(-21.5%) |
| Sep 2015 | - | -$2.86M(-27.1%) | -$8.48M(-23.2%) |
| Jun 2015 | - | -$2.25M(-24.4%) | -$6.88M(-18.9%) |
| Mar 2015 | - | -$1.81M(-16.2%) | -$5.78M(-29.0%) |
| Dec 2014 | -$4.48M(-406.6%) | -$1.56M(-23.3%) | -$4.48M(-22.9%) |
| Sep 2014 | - | -$1.26M(-9.1%) | -$3.65M(-52.8%) |
| Jun 2014 | - | -$1.16M(-127.3%) | -$2.39M(+6.5%) |
| Mar 2014 | - | -$509.00K(+29.5%) | -$2.56M(-6668.1%) |
| Dec 2013 | -$885.20K(+74.7%) | -$722.20K(+45.4%) | $38.90K(-94.9%) |
| Jun 2013 | - | -$1.32M(-163.5%) | $761.10K(-63.5%) |
| Mar 2013 | - | $2.08M | $2.08M |
| Dec 2012 | -$3.50M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Soleno Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Soleno Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of SLNO is -$69.10M
What is the all-time high annual cash from operations for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual cash from operations is -$885.20K
What is Soleno Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, SLNO annual cash from operations has changed by -$44.16M (-177.05%)
What is Soleno Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of SLNO is -$12.61M
What is the all-time high quarterly cash from operations for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly cash from operations is $2.08M
What is Soleno Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, SLNO quarterly cash from operations has changed by +$5.04M (+28.57%)
What is Soleno Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of SLNO is -$84.28M
What is the all-time high TTM cash from operations for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM cash from operations is $2.08M
What is Soleno Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, SLNO TTM cash from operations has changed by -$41.45M (-96.79%)